drugset / Trial / NCT07053085
A Study of Surgery and Radiotherapy in People With Breast Cancer
Phase 2
Recruiting
178 enrolled
Memorial Sloan Kettering Cancer Center
Gateway for Cancer Research · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The researchers are doing this study to see if the combination of surgery, locoregional radiation therapy, SBRT (stereotactic body radiation therapy), and the usual approach is more effective in treating oligometastatic HER2-positive breast cancer than the usual approach alone. The researchers will also study the side effects of the study treatment.
Timeline
- Start
- 2025-09-17
- Primary completion
- 2029-09-17
- Completion
- 2029-09-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Paclitaxel | Small molecule | — | — |
| Comparator | Pertuzumab | Monoclonal antibody | — | — |
| Comparator | Trastuzumab | Monoclonal antibody | — | — |